Ravidal 5000 INTERNATIONAL UNIT/1 TABLET Ürdün - İngilizce - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

ravidal 5000 international unit/1 tablet

شركة سافي فارما للصناعات الدوائية - savvy pharma - cholecalciferol 5000 international unit/1 tablet - 5000 international unit/1 tablet

INTERNATIONAL BIOLUX SELF POLISHING COPOLYMER MICRON 66 ANTIFOULING Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

international biolux self polishing copolymer micron 66 antifouling

akzo nobel pty limited - cuprous oxide; zinc pyrithione; liquid hydrocarbon - paint - cuprous oxide mineral-copper active 660.0 g/l; zinc pyrithione mineral-zinc active 64.0 g/l; liquid hydrocarbon solvent other 515.0 g/l - antifouling - boat hull (refer to label) - marine growth | barnacles | fresh-water fouling organisms | marine fouling organisms | mussels

CUE INJECTION Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

cue injection

international animal health products pty ltd - copper as calcium copper edetate - parenteral liquid/solution/suspension - copper as calcium copper edetate mineral-copper active 50.0 mg/ml - nutrition & metabolism - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - copper deficiency

Jurnista Prolonged Release Tablet 8mg Singapur - İngilizce - HSA (Health Sciences Authority)

jurnista prolonged release tablet 8mg

johnson & johnson pte. ltd. - (drug layer) hydromorphone hcl - tablet, extended release - 8.72mg - (drug layer) hydromorphone hcl 8.72mg

Osigraft Avrupa Birliği - İngilizce - EMA (European Medicines Agency)

osigraft

olympus biotech international limited - eptotermin alfa - tibial fractures - drugs for treatment of bone diseases, bone morphogenetic proteins - treatment of nonunion of tibia of at least 9 month duration, secondary to trauma, in skeletally mature patients, in cases where previous treatment with autograft has failed or use of autograft is unfeasible.

PIOGLITAZONE tablet ABD - İngilizce - NLM (National Library of Medicine)

pioglitazone tablet

international laboratories, llc - pioglitazone hydrochloride (unii: jqt35npk6c) (pioglitazone - unii:x4ov71u42s) - pioglitazone 15 mg - monotherapy and combination therapy pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see clinical studies (14) ]. important limitations of use pioglitazone tablets exert their antihyperglycemic effect only in the presence of endogenous insulin. pioglitazone tablets should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be effective in these settings. use caution in patients with liver disease [see warnings and precautions (5.3) ]. •   initiation in patients with established nyha class iii or iv heart failure [see boxed warning]. •   use in patients with known hypersensitivity to pioglitazone or any other component of pioglitazone tablets. teratogenic effects pregnancy category c. there are no adequate and well-controlled studies of pioglitazone hydrochloride in pregnant women. animal studies show increased rates of post-implantation loss, delayed development,

PIOGLITAZONE tablet ABD - İngilizce - NLM (National Library of Medicine)

pioglitazone tablet

international laboratories, llc - pioglitazone hydrochloride (unii: jqt35npk6c) (pioglitazone - unii:x4ov71u42s) - pioglitazone 15 mg - pioglitazone tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings [see clinical studies (14)] . pioglitazone tablets exert their antihyperglycemic effect only in the presence of endogenous insulin. pioglitazone tablets should not be used to treat type 1 diabetes or diabetic ketoacidosis, as it would not be effective in these settings. use caution in patients with liver disease [see warnings and precautions (5.3)]. do not initiate in patients with nyha class iii or iv heart failure [see boxed warning] . do not use in patients with a history of a serious hypersensitivity reaction to pioglitazone tablets or any of their ingredients. pregnancy category c. there are no adequate and well-controlled studies of pioglitazone tablets in pregnant women. animal studies show increased rates of post-implantation loss, delayed development, reduced fetal weights, and delayed parturition at doses 10 to 40 times the maximum re

Sytena 25 mg film-coated tablets Malta - İngilizce - Medicines Authority

sytena 25 mg film-coated tablets

farmak international sp. z o.o. aleja jana pawla ii 22 00-133 warsaw , poland - film-coated tablet - sitagliptin 25 mg - drugs used in diabetes

Sytena 50 mg film-coated tablets Malta - İngilizce - Medicines Authority

sytena 50 mg film-coated tablets

farmak international sp. z o.o. aleja jana pawla ii 22 00-133 warsaw , poland - film-coated tablet - sitagliptin 50 mg - drugs used in diabetes

Sytena 100 mg film-coated tablets Malta - İngilizce - Medicines Authority

sytena 100 mg film-coated tablets

farmak international sp. z o.o. aleja jana pawla ii 22 00-133 warsaw , poland - film-coated tablet - sitagliptin 100 mg - drugs used in diabetes